Market Access Why the Novo Nordisk Foundation is betting big on stem cells One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
